FDA Approves 1st Treatment for Niemann-Pick Disease, Type C
Nationwide Snack Recall Update As FDA Sets Highest Risk Level
The snacks now have a Class I risk level, meaning there is a "reasonable probability" they could cause "serious adverse ...
STAT1d
FDA’s new head of device safety held senior role at company troubled by safety warnings
“Olympus’ continued failure to meet FDA requirements demonstrates a troubling disregard for patient safety,” said Jeffrey ...
FDA finds some 'dairy-free' chocolate products contain milk
Consumers should be aware that some chocolate labeled as "dairy-free" actually contains milk, the U.S. Food and Drug ...
The American Journal of Managed Care1d
FDA Approves Amivantamab for EGFR-Positive NSCLC With Exon 19 Deletion, Exon 21 L858R Substitution
The FDA approval of amivantamab-vmjw (Rybrevant) in combination with chemotherapy is the first targeted treatment to cut ...
Medpage Today on MSN2d
FDA Rejects NK1R Antagonist for Gastroparesis
Support for the neurokinin-1 receptor (NK1R) antagonist included a negative phase III trial and a positive phase II study ...
FiercePharma1d
In addressing inspection shortfall, FDA says it's gaining more inspectors than it's losing
In its effort to play catch up after thousands of factory inspections were delayed during the coronavirus pandemic, the FDA ...
FDA says drug makers will stop producing fentanyl 'lollipops'
Controversial fentanyl lollipops and similar products will no longer be made by drug makers, the U.S. Food and Drug ...